← FDA DRUG APPROVALS
FDA ANDA · ANDA202564
CLINDAMYCIN PHOSPHATE AND TRETINOIN
Sponsor: ACTAVIS MID ATLANTIC
APPLICATION
ANDA202564
TYPE
ANDA
ORIGINAL APPROVAL
2015-06-12
LATEST ACTION
2015-06-12
ROUTE
TOPICAL
DOSAGE FORM
GEL
MARKETING STATUS
Prescription
Products
CLINDAMYCIN PHOSPHATE AND TRETINOINPrescription
CLINDAMYCIN PHOSPHATE 1.2%, TRETINOIN 0.025% · GEL · TOPICAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.